PRX-03140
From Wikipedia, the free encyclopedia
 |
This article provides insufficient context for those unfamiliar with the subject. Please help improve the article with a good introductory style. (December 2011) |
PRX-03140 is a partial agonist at the 5-HT4 receptor being developed by EPIX Pharmaceuticals for Alzheimer's disease.[1]
[edit] References
- ^ Shen, F (August 2011). "5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.". Neuropharmacology 61 (1-2): 69–79. doi:10.1016/j.neuropharm.2011.02.026. PMID 21392515.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
